Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-29 @ 10:52 PM
Study NCT ID:
NCT07285850
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2025-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
Sponsor:
Eastern Hepatobiliary Surgery Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-17
First Submit QC Date:
None
Study First Post Date:
2025-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED